COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience

Detalles Bibliográficos
Autores principales: Preziosa, Paolo, Rocca, Maria A., Nozzolillo, Agostino, Moiola, Lucia, Filippi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677903/
https://www.ncbi.nlm.nih.gov/pubmed/33216223
http://dx.doi.org/10.1007/s00415-020-10309-4
_version_ 1783612069300404224
author Preziosa, Paolo
Rocca, Maria A.
Nozzolillo, Agostino
Moiola, Lucia
Filippi, Massimo
author_facet Preziosa, Paolo
Rocca, Maria A.
Nozzolillo, Agostino
Moiola, Lucia
Filippi, Massimo
author_sort Preziosa, Paolo
collection PubMed
description
format Online
Article
Text
id pubmed-7677903
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76779032020-11-20 COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience Preziosa, Paolo Rocca, Maria A. Nozzolillo, Agostino Moiola, Lucia Filippi, Massimo J Neurol Letter to the Editors Springer Berlin Heidelberg 2020-11-20 2021 /pmc/articles/PMC7677903/ /pubmed/33216223 http://dx.doi.org/10.1007/s00415-020-10309-4 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editors
Preziosa, Paolo
Rocca, Maria A.
Nozzolillo, Agostino
Moiola, Lucia
Filippi, Massimo
COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
title COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
title_full COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
title_fullStr COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
title_full_unstemmed COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
title_short COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
title_sort covid-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677903/
https://www.ncbi.nlm.nih.gov/pubmed/33216223
http://dx.doi.org/10.1007/s00415-020-10309-4
work_keys_str_mv AT preziosapaolo covid19incladribinetreatedrelapsingremittingmultiplesclerosispatientsamonocentricexperience
AT roccamariaa covid19incladribinetreatedrelapsingremittingmultiplesclerosispatientsamonocentricexperience
AT nozzolilloagostino covid19incladribinetreatedrelapsingremittingmultiplesclerosispatientsamonocentricexperience
AT moiolalucia covid19incladribinetreatedrelapsingremittingmultiplesclerosispatientsamonocentricexperience
AT filippimassimo covid19incladribinetreatedrelapsingremittingmultiplesclerosispatientsamonocentricexperience

Ejemplares similares